Isomorphic Labs raises $5 billion, Google DeepMind releases AlphaGenome 2, and more - Life AI Weekly #94
In this edition, covering 11 to 17 November:
- Isomorphic Labs raised $5 billion in a Series C round co-led by Greenoaks and Sequoia, with Andreessen Horowitz and Alphabet also investing.
- Google DeepMind released AlphaGenome 2, a DNA model trained on more than 107 million cell profiles across 68 tissues, for research use only.
- OpenAI says its computer-use agents can handle EHR tasks for clinicians, with CVS Health and Cigna among users.
This spot is open for 2027. One company puts its name on every Life AI Weekly, which has 3,700+ subscribers. See what's included
From our lists
An AI Brief list covers companies that use AI to discover and develop drugs.
Isomorphic Labs
Isomorphic Labs, the London based AI drug design company led by Demis Hassabis, raised $5 billion in a Series C round. Greenoaks and Sequoia co-led the round, with Andreessen Horowitz and Alphabet also investing. Isomorphic Labs
Genomics and research models
Google DeepMind introduced AlphaGenome 2, a DNA model trained on more than 107 million cell profiles across 68 tissues. It predicts how genetic variants affect specific cell types and states, identifies nearly twice as many gene expression changing variants as the previous model and adds DNA methylation predictions. It is available through the AlphaGenome API for noncommercial research and in private preview for commercial research, and it is not approved for clinical or diagnostic use. AlphaGenome 2
Hong Kong based BioMap announced collaborations with 11 organisations in drug research, traditional Chinese medicine, agricultural breeding and biomanufacturing, including the University of Hong Kong, Hong Kong Baptist University, Temasek Life Sciences Laboratory, Harbour BioMed and Revvity. BioMap
Cradle expanded use of its AI protein engineering platform across argenx's scientists and antibody discovery programs after initial work helped optimise antibody leads and generate new candidates. Biointron tested 30 antibody candidates designed by Molence Bio's Mol-1 model in its RushDATA wet lab service, and 23 met at least three of four developability criteria. Cradle and argenx · Biointron and Molence Bio
Drug discovery funding and deals
Flagship Pioneering committed £100 million to a London lab, its first company creation unit outside the US. The lab will build AI native platform companies and hire about 50 people in the UK. Flagship Pioneering
Dallas based AI company Astromech will acquire Form Bio in an all stock deal valued at $230 million, combining Astromech's evolutionary biology models with Form Bio's tools for designing and testing genetic medicines. Form Bio co founder Andrew Busey will become Astromech's Chief AI Officer and Head of Technology. Astromech and Form Bio
Paris based Orakl Oncology raised $34 million in a Series A led by Norrsken VC and Singular. It plans to extend its AI platform from colorectal and pancreatic cancers to lung and gastric cancers, increase data generation fivefold and apply its predictions to more than 10 drug programs in the US and UK. Orakl says the platform predicts cancer trial outcomes with 90% accuracy; that figure has not yet been shown to improve drug development success rates. Orakl Oncology
Lithuanian company Biomatter raised $18 million in a Series A led by Astanor to design custom enzymes with computational models and lab testing, and plans a 2,000 square metre design and testing facility in Vilnius in 2027. Araceli Biosciences, which develops cellular imaging platforms and AI analysis software for drug discovery, added Jeff Swickard as an investor in its $4.5 million round. Biomatter · Araceli Biosciences
Clinical research platforms
SAS and Posit PBC will help life sciences organisations use SAS, R and Python in managed environments, starting with clinical development. The work integrates SAS Viya and SAS Clinical Acceleration with Posit tools and supports regulatory requirements, access controls and reproducible workflows. SAS and Posit
Dyania Health will run its Synapsis AI platform on hospital infrastructure with Nvidia, so health systems can analyse unstructured patient records without moving data outside their networks. Cleveland Clinic used the platform to analyse up to 16 years of records from 7,812 aortic valve replacement patients and build models for valve deterioration and repeat procedures. Dyania Health
ArisGlobal says Amazon Bedrock prompt caching in its NavaX engine served 65% of input tokens for adverse event processing from cache and lowered its monthly inference spending by about 40%. Surgo Health launched Derin, a research platform that analyses patients' and providers' experiences through AI moderated conversations; Upstream USA uses it to study contraceptive care. ArisGlobal · Surgo Health
Clinical decision support
Wolters Kluwer Health agreed to acquire San Francisco based AgileMD, an AI clinical decision support company, for up to $100 million, with $40 million upfront and the rest tied to performance targets. AgileMD's 23 employees will join Wolters Kluwer Health, and the deal is expected to close in the first quarter of 2027 or sooner, subject to approvals. Wolters Kluwer and AgileMD
Elsevier says ClinicalKey AI can now access a patient's full medical record within the EHR and compare treatment plans with evidence based clinical content. The US rollout follows its June 2026 acquisition of Wellsheet, and the tool is used at more than 1,200 hospital sites. Lapsi Health will add clinical policies from the American College of Emergency Physicians to Keikku Reference, its cited clinical reference and decision support platform; the collaboration has no commercial terms. Elsevier · Lapsi Health and ACEP
Clinical studies
An interim analysis of the randomised, single centre ALLIANCE trial, reported at ESMO, found that clinicians using ChatGPT Plus recorded more chemotherapy related toxicities among 56 patients with breast or colorectal cancer. The additional reports did not significantly improve toxicity management or quality of life, and ChatGPT Plus was used in 47% of monthly reports in the assisted group. ALLIANCE trial
The PERISCOPE machine learning models predicted in hospital and six month mortality after PCI for STEMI more accurately than the GRACE 2.0 score in US and Dutch databases, according to the European Society of Cardiology. The researchers say prospective studies are needed to test whether using the models improves outcomes. PERISCOPE
A study in the November 2026 Journal of Cardiac Failure found that adding EchoGo HF AI analysis of a routine echocardiogram to the H2FPEF score identified 78% of patients with hemodynamically confirmed HFpEF, compared with 48% using the score alone. Thyroscope and The Orbital Radiology Center signed a memorandum of understanding to study thyroid eye disease monitoring with Thyroscope's Glandy smartphone AI platform. EchoGo HF · Thyroscope and TORC
In a randomised trial at Asan Medical Center in Seoul, 45 children with cerebral palsy who used GemGem Therapeutics' camera based game GemGem400 at home for eight weeks improved more in hand dexterity and pinch strength than controls. The study was small, at one centre and without long term follow up; the game is meant to complement in person occupational therapy. Linus Health will present six studies at CTAD 2026 in Boston on AI based digital cognitive assessments, amyloid prediction, dementia risk estimation and patient centred outcome measures. GemGem Therapeutics · Linus Health
The NHS is trialling Ufonia's Dora Care, a generative AI telephone assistant that monitors patients with osteoporosis, in a voluntary two year project with Newcastle University and the University of York, funded by Innovate UK. The calls supplement existing care. EORTC joined ResPECT, a four year project led by Heidelberg University with 22 partners in eight European countries, to build a multilingual AI assistant for cancer and mental health care; clinical testing will involve people with early stage breast cancer or moderate to severe depression. Dora Care · ResPECT
Regulators and clearances
Bracco and Avicenna.AI received FDA 510(k) clearance for UPTUNITY | Aneurysm, software that helps specialists detect brain aneurysms larger than 3 mm on cerebral CT angiography and monitor known aneurysms over time. AI4Eyes Medical Technologies completed FDA establishment registration and device listing for its eye care platform as a Class I, 510(k) exempt device. Skribe Medical's Aurora wearable cardiac monitor, studied in more than 800 cancer patients in the NOECHO trial, was selected for the FDA's READI-Home Innovation Challenge, which gives early FDA feedback on home use but no marketing authorisation. Bracco and Avicenna.AI · AI4Eyes · Skribe Medical
From 16 November, new FDA documents use 'Super Intelligence' and 'SI' in place of AI under Executive Order 14434; the agency says the change creates no new requirements for companies. Ukraine's Health Ministry is preparing legislation on medical AI with risk classes and safety, transparency and accountability requirements; a ministry survey found that 80.5% of more than 7,000 medical workers already use AI tools. NHS England removed a webpage claiming 137 trusts were live with and benefiting from Palantir's Federated Data Platform after 29 trusts said they were not using all or most of it. FDA · Ukraine · NHS England and Palantir
OpenAI and ChatGPT
OpenAI says its computer-use agents can handle EHR tasks for clinicians, with CVS Health and Cigna among users. Physicians rated 99% of 325 reviewed GPT-6 Astra tasks safe, and OpenAI says CVS Health cleared a months long backlog over a weekend. OpenAI agents
US Senator Patty Murray asked OpenAI to explain how ChatGPT allegedly advised Seattle resident Wan Bowen to reduce her epilepsy medication, hide the change from her doctor and disregard seizure symptoms, as claimed in a lawsuit over her death. Murray asked for details on safeguards, monitoring of medical advice, safety in languages other than English and the removal of GPT-4o by 1 December 2026. Senator Murray
Photon released a ChatGPT plugin that lets licensed clinicians draft, review, authorise and send prescriptions using patient and treatment context. Luma Health added a ChatGPT plugin with 59 actions, such as appointment preparation, rescheduling and colonoscopy preparation, which follows each health system's permissions and reads from and writes to the EHR. Subsalt launched a ChatGPT plugin that combines OpenAI models with its HIPAA compliant de identification platform, so health system teams can analyse patient data without access to identifiable information. Mexico's president met OpenAI president Greg Brockman to discuss AI in healthcare; no OpenAI role in the government's health council was announced. Photon · Luma Health · Subsalt · OpenAI in Mexico
Patient apps and consumer health
Apple's Health AI Usage Study, built with OpenEvidence, lets up to 200,000 US participants ask health questions and studies their trust and comprehension. Ochsner Health uses Lumeris's Tom for Mia, a conversational patient service, and Lumeris reports 28% fewer emergency visits among patients using it. Apple and OpenEvidence · Lumeris
KINSYN, co founded by Chris Hemsworth, launched in the US with physician guided care, prescription therapies, supplements and lab testing, using its own AI to help providers make individual recommendations. LERA Health launched a women's health service with at home testing, an AI health coach and human clinical support, starting with a $549 assessment and $29 a month. Medavize is giving members of Dateability, a dating app for disabled and chronically ill people, a 30 day free trial of its app with AI health insights. HearUSA made Widex Allure AI RIC hearing aids, with AI noise management and Zen Therapy for tinnitus, available across the US. KINSYN · LERA Health · Medavize · HearUSA
b.well Connected Health launched health.skills, a library of expert written workflows and safety checks that AI assistants use with a person's FHIR record, available through its Health AI SDK and other MCP capable assistants. Simple HealthKit and Waters Corporation will expand at home cervical cancer screening in the US with the FDA cleared Onclarity HPV Self Collection Kit and Simple HealthKit's AI powered platform. b.well · Simple HealthKit and Waters
Imaging and devices
Remedy Robotics raised $62 million in a Series B led by DCVC for its AI enabled endovascular robot. The money funds the trial with the University of California that is meant to support FDA approval. South Korean startup MedInTech raised a $25.7 million Series C co-led by Atinum Investment and KB Investment to expand its AI robotic endoscopes and develop treatment and surgical robots. Remedy Robotics · MedInTech
RADPAIR will integrate its cloud based agentic AI reporting into Novarad's NovaPACS Enterprise Imaging, so radiologists can review images, see prior studies and finalise reports in one workflow. DIAGENS introduced a CT model for 509 chest and abdominal diseases and findings, with a macro averaged AUC of 0.855 in internal validation on nearly 40,000 CT examination and report pairs. SmileFy launched an AI Smile Designer that analyses patient photos and intraoral scans and suggests tooth specific treatments, with dentists keeping control of clinical decisions. RADPAIR and Novarad · DIAGENS · SmileFy
Deals, funding and results
Elligint Health is acquiring Israeli startup Laguna Health in a deal reportedly valued at tens of millions of dollars; Laguna will become Elligint's AI development arm. Zus Health raised $33 million in a Series B led by Drive Capital for its connected patient record platform, data network and AI clinical workflows. Finnish startup Treat raised €3 million in pre seed funding led by byFounders and Illusian for AI intake that briefs doctors before a digital consultation. Elligint and Laguna · Zus Health · Treat
Swiss neurotech company Indivi acquired Cogitat, an Imperial College London spinout whose deep learning models decode cognitive function from EEG signals, for brain health research and clinical trials. Bask Health acquired Telehealth.com and plans an AI telehealth marketplace in the first quarter of 2027, where patients and AI agents can book care with more than 500 virtual care brands through ChatGPT, Claude or Grok accounts. Indivi and Cogitat · Bask Health
Google.org granted Froncort.AI $2.3 million to build mAI-NETRA, a mobile tool that tells health workers where to screen for TB and other diseases. Redesign Health started a growth equity practice, led by Richie Chaikof, for minority investments in healthcare IT, AI enabled services and clinical AI. Froncort.AI · Redesign Health
DarioHealth reported third quarter revenue of $5.3 million, up 6%, and broader deployment of DarioIQ. Marpai reported third quarter revenue of $4.4 million, up 9.6%, and says AI agents handle routine provider questions on claim status and eligibility. DarioHealth · Marpai
Surveys and reports
Menlo Ventures says healthcare AI spending grew 2.5 times to $3.7 billion in 2026, that scribes have become a commodity as EHR vendors move in, and that drug discovery, clinical copilots and patient engagement are growing fastest. CHIME's 2026 Most Wired report, covering more than 48,800 facilities, found that 93.2% of participating organisations use AI, fully adopted generative AI rose from 31.0% to 54.8% in a year, and 16.4% of AI users have fully documented processes for monitoring models after deployment. Menlo Ventures · CHIME
Bain & Company found that only about 40% of US health system administrators can clearly measure returns from AI, and that physician satisfaction fell to its lowest level since 2017. In a Penguin Ai survey of 500 US adults, 62% of those who faced a prior authorisation delay, denial or medication restriction gave up on care. In Cohere Health's survey of 200 clinicians and office administrators, clinician reports of patients abandoning treatment because of prior authorisation delays fell from 55% to 28%. Bain · Penguin Ai · Cohere Health
Adonis's Q4 2026 Payer Forecast names payer policy changes, payer specific payment patterns and gaps in automation as risks to provider reimbursement in 2027. The American Institutes for Research launched the AI in Health Network, with eight projects on the benefits, risks and real world use of AI in healthcare and public health. A policy brief from the WHO Asia-Pacific Centre for Environment and Health covers AI forecasting of climate related health risks such as disease, heat, air quality and extreme weather in the Western Pacific Region. Adonis · American Institutes for Research · WHO
Care operations and agents
Optum is working with California Medicaid insurer Alameda Alliance for Health to automate claims adjudication with agentic AI, starting with claims workflows. Basata will run AI voice agents for intake, referrals, insurance checks and scheduling across more than 60 Unio Specialty Care locations in California. Sempre Health launched Atlas, an AI voice service for enrollment, prior authorisations, coverage questions and refills for drugmakers, health plans and PBMs. Optum · Basata · Sempre Health
Shore Medical Center and Shore Physicians Group in New Jersey will adopt Oracle Health's AI powered EHR, with AI drafted notes and AI order creation, and expect to finish by December 2027. Greenway Health made its Novare AI platform available to ambulatory practices, and Fold Health launched an AI operating layer for outreach, scheduling, documentation and follow up across EHRs. Kno2 is working with Microsoft to bring clinical data exchanged across providers into Azure Health Data Services, Fabric and OneLake. Shore and Oracle Health · Greenway Health · Fold Health · Kno2 and Microsoft
League made AI Front Door for payers and AI Care Companion for providers generally available on its Forge platform, for benefits navigation, care finding, outreach and coaching with human escalation. Kipu Health and RVK AI will provide voice and web agents that answer behavioural health admissions inquiries and transfer suitable callers to staff. Experity expanded telehealth, occupational medicine, revenue cycle and real time eligibility features for more than 6,500 urgent care clinics, and Zentist will offer AI eligibility verification, remittance processing and payment posting through Asprodental's practice management software. League · Kipu Health and RVK AI · Experity · Zentist
LateralCare signed partnerships with six healthcare associations in five states for its AI revenue cycle platform. Capline Dental Services says AI workflows helped providers reach active payer status 60% faster, with staff reviewing applications before submission. Pitcher made multi avatar AI roleplay generally available for life sciences field teams. LateralCare · Capline · Pitcher
The Rx Assistant launched Builder, a no code platform for drugmakers to create, approve and deploy AI experiences for patients and healthcare professionals, with adverse event reporting built in. PHM, part of Publicis Groupe, invested in ODAIA and became the exclusive US agency partner for its AI commercial intelligence platform for pharmaceutical brands. The Rx Assistant · PHM and ODAIA
Documentation
Concurrence will provide an AI clinical copilot that transcribes telehealth sessions and supports note taking for Thriveworks' 2,800 mental health clinicians. OptiMantra launched AI Scribe in its EHR, which records visits with patient consent and drafts notes for providers to review and sign, from $19 per provider per month. Berry Street acquired MyScribe's technology; founder Dr. Wasif Bokhari joined as Lead AI Engineer and the MyScribe service is being wound down. Concurrence and Thriveworks · OptiMantra · Berry Street
Appointments
ScreenPoint Medical appointed Parul Sharma chief commercial officer to lead global sales, marketing, customer success, partnerships and revenue operations. Concurrence appointed Satwik Seshasai, former CTO at Main Street Health and Atria, as president to lead its commercial and technical expansion. ScreenPoint Medical · Concurrence
Also
Taiwan's T+ MedIC Accelerator named Xindian Zhiyi, a Tri Service General Hospital team working on AI assisted ECG interpretation, and DeepRad.AI, which combines low dose chest CT and AI to assess lung, cardiovascular and bone health risks, as its winners. T+ MedIC Accelerator
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 MegaRobo raises nearly $200 million to let AI run real lab experiments Nov 18 AlphaFold screen maps nearly 2,900 likely interactions among human mitochondrial proteins Nov 18 Hone Health raises $228 million to expand AI-enabled longevity care Nov 18 Tesorai raises $5.3 million to make raw lab data searchable with AI Nov 18 nference and Novo Nordisk partner on AI research into obesity, diabetes and heart diseaseLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
